Request Deal Involvement

Novo Holdings, RA Capital Management, Royalty Pharma, SR One, and TPG Life Sciences Innovations led a $112.25m Series C round in Elektrofi.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Morgan Lewis & Bockius

legal advisors

Morgan Lewis & Bockius

Gibson Dunn & Crutcher

legal advisors

Gibson Dunn & Crutcher

or

Principals

ELI LILLY AND COMPANY

bidder

ELI LILLY AND COMPANY

JANUS HENDERSON INVESTORS

bidder

JANUS HENDERSON INVESTORS

NOVO HOLDINGS A/S

bidder

NOVO HOLDINGS A/S

ROYALTY PHARMA

bidder

ROYALTY PHARMA

SR ONE LTD

bidder

SR ONE LTD

ELEKTROFI

target

ELEKTROFI

CATALIO CAPITAL MANAGEMENT

bidder

CATALIO CAPITAL MANAGEMENT

RA CAPITAL MANAGEMENT

bidder

RA CAPITAL MANAGEMENT

TPG CAPITAL LP

bidder

TPG CAPITAL LP

SAMSARA BIOCAPITAL

bidder

SAMSARA BIOCAPITAL

BRAIDWELL LP

bidder

BRAIDWELL LP

CHECKPOINT CAPITAL

bidder

CHECKPOINT CAPITAL

DEEP TRACK CAPITAL

bidder

DEEP TRACK CAPITAL

GENERAL CATALYST PARTNERS

bidder

GENERAL CATALYST PARTNERS

KEARNY VENTURE PARTNERS

bidder

KEARNY VENTURE PARTNERS

LOGOS CAPITAL

bidder

LOGOS CAPITAL

MARSHALL WACE

bidder

MARSHALL WACE

PARADIGM BIOCAPITAL

bidder

PARADIGM BIOCAPITAL

WOODLINE PARTNERS

bidder

WOODLINE PARTNERS

LEERINK PARTNERS LLC

bidder

LEERINK PARTNERS LLC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite